PD-1 Antibody (Immunohistochemistry)

PD-1 Antibody (Immunohistochemistry)

The PD-1 (Programmed Death-1) Antibody is a specific immunohistochemical marker used for the identification of Angioimmunoblastic T-Cell Lymphoma (AITL) and immune-related studies.
PD-1 is expressed on activated T-cells, B-cells, and myeloid cells, playing a central role in immune tolerance and regulation.
Unlike CD10 and BCL6, PD-1 is expressed by few B-cells, making it a more specific marker for identifying follicular T-cell origin lymphomas.

🔬 Features and Benefits

• Specific for AITL: Identifies follicular T-cell origin lymphomas

• Distinct cytoplasmic/membrane staining: Brown staining pattern in positive cells

• Clinically valuable: Helps differentiate T-cell lymphomas from other lymphoid malignancies

• Compatible with standard IHC protocols

• Excellent stability: 18-month shelf life at 2–8 °C

💡 Diagnostic Applications

• Diagnosis of Angioimmunoblastic T-Cell Lymphoma (AITL)

• Evaluation of PD-1/PD-L1 immune checkpoint pathways

• Research in tumor immunology and immunotherapy

🌐 Fardad Azma Rad Co.

Fardad Azma Rad Co., the exclusive representative of Talent Biomedical in Iran, provides high-quality immunohistochemistry antibodies, including PD-1.
Committed to global standards and diagnostic excellence, the company supports molecular pathology laboratories across Iran.

“Download Brochure”